title: Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib.
authors.affiliation: Department of Haematology, Plymouth Hospitals NHS Trust, Plymouth, UK.
authors.forename: David L
authors.initials: DL
authors.lastname: Tucker
authors.affiliation: Department of Haematology, Plymouth Hospitals NHS Trust, Plymouth, UK.
authors.forename: Loredana
authors.initials: L
authors.lastname: Mihailescu
authors.affiliation: Department of Radiology, Plymouth Hospitals NHS Trust, Plymouth, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Riordan
authors.affiliation: Department of Haematology, Plymouth Hospitals NHS Trust, Plymouth, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Rule
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002113:Calcification, Physiologic / Q000187:drug effects; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D010014:Osteolysis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine
keywords: ibrutinib; lymphoma; lytic bone disease; small lymphocytic lymphoma